Stay updated on Pembrolizumab in Refractory Meningioma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Refractory Meningioma Clinical Trial page.

Latest updates to the Pembrolizumab in Refractory Meningioma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now reflects that recruitment has ended by noting 'No longer looking for participants,' signaling no active enrollment for this study. In addition, the page adds help-related links (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment label while updating the revision metadata to v3.6.0.SummaryDifference0.6%

- Check16 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's content or metadata. This change does not modify the substantive study details or results.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision tag on the page updated from v3.5.3 to v3.5.4, signaling a new deployment of the page. This update does not change the trial details or related information.SummaryDifference0.1%

- Check59 days agoChange DetectedThis update changes the ClinicalTrials.gov page’s displayed revision/version from v3.5.0 to v3.5.3, indicating an internal platform release without altering the study information presented.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision label updated to v3.5.0; the previous v3.4.3 label was removed.SummaryDifference0.1%

- Check110 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Refractory Meningioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Refractory Meningioma Clinical Trial page.